Literature DB >> 8428929

Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.

J Slack1, C J McMahan, S Waugh, K Schooley, M K Spriggs, J E Sims, S K Dower.   

Abstract

Interleukin (IL)-1 refers to a group of three polypeptide hormones with a wide range of cellular targets. Two types of IL-1 receptor have been identified and characterized by cDNA cloning. Both human type I and type II IL-1 receptors contain extracellular domains of approximately 310 residues and a single membrane-spanning region. The type I receptor contains a cytoplasmic domain of 213 residues. The cytoplasmic region of the type II receptor is 29 residues in length. It has been found recently that a number of cells express both forms of receptor. By analogy with other cytokine receptor systems, the two IL-1 receptors might be expected to form a heterodimeric complex, the type II receptor being an alpha-chain-like structure, functioning only to bind ligand, and associating with the type I receptor (a beta-chain-like structure) which would transduce signals. In this report we show that this is not the case, but rather that IL-1, when complexed to type II receptor, cannot bind type I receptors, and vice versa. These data show that the complex patterns often observed for IL-1 binding to cells cannot be accounted for by the same type of mechanism that underlies the behavior of, for example, the IL-2 system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Anti-interleukin 1alpha autoantibodies.

Authors:  P Miossec
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Regulation of IL-1 signaling through control of focal adhesion assembly.

Authors:  Qin Wang; Julie Delcorde; Tracy Tang; Gregory P Downey; Christopher A McCulloch
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

3.  Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.

Authors:  Daniel R Johnson; Jason C O'Connor; Robert Dantzer; Gregory G Freund
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

4.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

Authors:  J A Symons; P R Young; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

6.  The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.

Authors:  D Burger; R Chicheportiche; J G Giri; J M Dayer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.

Authors:  R W Groves; L Sherman; H Mizutani; S K Dower; T S Kupper
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Authors:  G Poli; A L Kinter; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

Review 10.  Cytokines and reproduction.

Authors:  C Simón; M L Polan
Journal:  West J Med       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.